Impaired Glucose Tolerance Completed Phase Trials for Sitagliptin (DB01261)

Also known as: Prediabetic State (IGT) / Impaired Glucose Tolerance (IGT) / IGT - Impaired Glucose Tolerance / Glucose tolerance impaired / Impaired Glucose Tolerance (Prediabetes) / Pre-diabetic State / Prediabetic State / Pre-Diabetic / Pre Diabetes / Pre-Diabetes / Pre Diabetic / Prediabetes / Prediabetic / Latent diabetes / Chemical diabetes / Glucose intolerance / Malabsorption of glucose (disorder) / Impaired glucose tolerance (disorder) / Prediabetes (finding) / Borderline diabetes

IndicationStatusPhase
DBCOND0030184 (Impaired Glucose Tolerance)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01488279Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid TherapyTreatment
NCT00775684Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassTreatment
NCT03659461Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes MellitusTreatment